musclemania70
New member
After speaking with TWO representatives from Vertex IN PERSON, they both confirmed that the 770/809 trials will be scrapped alltogether if the 661 is more beneficial. They have findings that 661 will most likely take over and replace the 770/809 combo.
You may have already figured this out. But I wanted to hear it from Vertex myself. And I talked to them in person.
Kind of a let down for most of us because that means they are starting all over from square one with the 661 for the Delta 508s.
Other mutations may indeed be affected by the Kalydeco but the results may not be as long lasting or as powerful as it would be with the g551d (you probably already realized this).
Anyhow, thanks people for participating in the trials and helping to get these drugs studied. If it weren't for you, there would be little hope.
Hopefully, you have time on your side and you are far from 'needing' these drugs tosaving your lung health.
You may have already figured this out. But I wanted to hear it from Vertex myself. And I talked to them in person.
Kind of a let down for most of us because that means they are starting all over from square one with the 661 for the Delta 508s.
Other mutations may indeed be affected by the Kalydeco but the results may not be as long lasting or as powerful as it would be with the g551d (you probably already realized this).
Anyhow, thanks people for participating in the trials and helping to get these drugs studied. If it weren't for you, there would be little hope.
Hopefully, you have time on your side and you are far from 'needing' these drugs tosaving your lung health.